$2.55T
Total marketcap
$181.52B
Total volume
BTC 50.01%     ETH 15.86%
Dominance

Catalyst Pharmaceuticals CPRX Stock

16.08 USD {{ price }} 0.062229% {{change_pct}}%
Exchange
NasdaqCM
Market Cap
1.9B USD
LOW - HIGH [24H]
15.75 - 16.39 USD
VOLUME [24H]
1.07M USD
{{ volume }}
P/E Ratio
25.52
Earnings per share
0.63 USD

Catalyst Pharmaceuticals Price Chart

Catalyst Pharmaceuticals CPRX Financial and Trading Overview

Catalyst Pharmaceuticals stock price 16.08 USD
Previous Close 11.83 USD
Open 11.83 USD
Bid 0 USD x 1200
Ask 0 USD x 1800
Day's Range 11.78 - 12.46 USD
52 Week Range 6.29 - 22.11 USD
Volume 1.91M USD
Avg. Volume 1.9M USD
Market Cap 1.31B USD
Beta (5Y Monthly) 1.09683
PE Ratio (TTM) 13.744445
EPS (TTM) 0.63 USD
Forward Dividend & Yield N/A (N/A)
Ex-Dividend Date N/A
1y Target Est 21.4 USD

CPRX Valuation Measures

Enterprise Value 1.11B USD
Trailing P/E 13.744445
Forward P/E 7.929487
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm) 5.1160808
Price/Book (mrq) 3.926984
Enterprise Value/Revenue 4.33
Enterprise Value/EBITDA 8.683

Trading Information

Catalyst Pharmaceuticals Stock Price History

Beta (5Y Monthly) 1.09683
52-Week Change 91.78%
S&P500 52-Week Change 20.43%
52 Week High 22.11 USD
52 Week Low 6.29 USD
50-Day Moving Average 14.56 USD
200-Day Moving Average 15.33 USD

CPRX Share Statistics

Avg. Volume (3 month) 1.9M USD
Avg. Daily Volume (10-Days) 1.58M USD
Shares Outstanding 106.08M
Float 89.03M
Short Ratio 4.07
% Held by Insiders 5.94%
% Held by Institutions 82.71%
Shares Short 9.16M
Short % of Float 10.90%
Short % of Shares Outstanding 8.64%

Dividends & Splits

Trailing Annual Dividend Rate 0
Trailing Annual Dividend Yield 0%
5 Year Average Dividend Yield N/A
Payout Ratio 0
Last Split Factor

Financial Highlights

Fiscal Year

Fiscal Year Ends December 31, 2022
Most Recent Quarter (mrq) March 31, 2023
Next Fiscal Year End December 31, 2023

Profitability

Profit Margin 38.75%
Operating Margin (ttm) 46.81%
Gross Margin 77.23%
EBITDA Margin 49.86%

Management Effectiveness

Return on Assets (ttm) 22.94%
Return on Equity (ttm) 35.89%

Income Statement

Revenue (ttm) 256.48M USD
Revenue Per Share (ttm) 2.47 USD
Quarterly Revenue Growth (yoy) 98.09%
Gross Profit (ttm) 160.02M USD
EBITDA 127.89M USD
Net Income Avi to Common (ttm) 99.41M USD
Diluted EPS (ttm) 0.9
Quarterly Earnings Growth (yoy) 123.30%

Balance Sheet

Total Cash (mrq) 148.25M USD
Total Cash Per Share (mrq) 1.4 USD
Total Debt (mrq) 3.81M USD
Total Debt/Equity (mrq) 1.14 USD
Current Ratio (mrq) 3.508
Book Value Per Share (mrq) 3.15

Cash Flow Statement

Operating Cash Flow (ttm) 119.64M USD
Levered Free Cash Flow (ttm) -74171376 USD

Profile of Catalyst Pharmaceuticals

Country United States
State FL
City Coral Gables
Address 355 Alhambra Circle
ZIP 33134
Phone 305 420 3200
Website https://www.catalystpharma.com
Industry Biotechnology
Sector(s) Healthcare
Full Time Employees 82

Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthenic syndrome (LEMS); and Ruzurgi for the treatment of pediatric LEMS patients. The company develops Firdapse for the treatment of MuSK antibody positive myasthenia gravis and spinal muscular atrophy type. It has license agreements with BioMarin Pharmaceutical Inc.; and collaboration and license agreement with Endo Ventures Limited for the development and commercialization of generic Sabril tablets. Catalyst Pharmaceuticals, Inc. was founded in 2002 and is based in Coral Gables, Florida.

Q&A For Catalyst Pharmaceuticals Stock

What is a current CPRX stock price?

Catalyst Pharmaceuticals CPRX stock price today per share is 16.08 USD.

How to purchase Catalyst Pharmaceuticals stock?

You can buy CPRX shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.

What is the ticker symbol for Catalyst Pharmaceuticals?

The stock symbol or ticker of Catalyst Pharmaceuticals is CPRX.

Which industry does the Catalyst Pharmaceuticals company belong to?

The Catalyst Pharmaceuticals industry is Biotechnology.

How many shares does Catalyst Pharmaceuticals have in circulation?

The max supply of Catalyst Pharmaceuticals shares is 117.86M.

What is Catalyst Pharmaceuticals Price to Earnings Ratio (PE Ratio)?

Catalyst Pharmaceuticals PE Ratio is 25.52381000 now.

What was Catalyst Pharmaceuticals earnings per share over the trailing 12 months (TTM)?

Catalyst Pharmaceuticals EPS is 0.63 USD over the trailing 12 months.

Which sector does the Catalyst Pharmaceuticals company belong to?

The Catalyst Pharmaceuticals sector is Healthcare.

Catalyst Pharmaceuticals CPRX included in indexes

Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
Name Name Price Price 24h%
7d chart
24h% & 7d
VOL Volume 24h low 24h high Volume
{{ item.name }} {{ item.symbol }} {{ item.price }} {{ item.price_usd }}
{{ item.change_pct }}
{{ item.volume }} {{ item.volume_usd }} {{ item.low }} {{ item.low_usd }} {{ item.high }} {{ item.high_usd }} {{ item.components_count }} {{ item.volume }} {{ item.volume_usd }}
NASDAQ Composite IXIC 16103.45 USD
+0.82
4.52B USD 16094.17 USD 16247.59 USD 4.52B USD
NASDAQ Capital Market Composite RCMP 116.84 USD
-0.68
116.47 USD 117.72 USD
Nasdaq AlphaDEX Multi Cap Growt NQDXUSMLTCG 2568.29 USD
+0.16
2566.7 USD 2581.47 USD
NASDAQ HealthCare IXHC 986.88 USD
-0.25
986.44 USD 994.67 USD
NASDAQ Composite Total Return I XCMP 19565.06 USD
+0.82
19553.78 USD 19740.18 USD
Nasdaq US 700 Small Cap Index NQUS700SC 2078.81 USD
-0.4
2075.76 USD 2093.28 USD